VB100 Spring Strategic Launch Day: Five Major Innovations Set to Reshape China's MedTech Landscape
The innovative healthcare industry is undergoing a paradigm shift, with new business models and technological applications continuously emerging. The daily deluge of information—from new product launches and project initiations to successful funding rounds and strategic realignments—can sometimes obscure the very innovations that truly drive the industry forward.
VCBeat—A healthcare media outlet born in 2014, the inaugural year of China’s internet healthcare era. As an observer and recorder of the innovative healthcare industry, it has continuously strengthened its core competency in “brand communication.” We have found that powerful brand communication capability consists of four key elements: communication heat sources, communication formats, channel influence, and potential energy factors, adhering to the following “Brand Communication Power” law:
Brand Communication Power F = Communication Heat Source E × Communication Form α × Channel Influence β × Potential Energy Factor γ
Through this core formula, we believe that staging a highly ceremonial launch event to create a focal point and tipping point, followed by a round of promotional campaigns, represents the most powerful way for enterprises and institutions to make their voices heard. Meanwhile, standalone information releases are fleeting in today’s deluge of content and fail to generate significant impact within the industry; however, aggregating major announcements can yield greater momentum for dissemination.
In December 2018, VCBeat hosted China’s first healthcare industry launch event—the VB100 Launch Day. In collaboration with eight enterprises and institutions, including Alibaba Cloud, Deshang Yunxing, VoxelCloud, NVIDIA, Xiao Dou Miao & Mommy Knows, Yixu Medical, Health Benefit, and DHIC, we unveiled new developments across five key areas: new products, financing, reports, strategies, and partnerships. By concentrating the release of extensive information, we aimed to accelerate information equilibrium within the industry, thereby fostering new technological innovations, breakthroughs, and industrial collaborations.
At the beginning of 2019, we hosted the VB100 New Year Strategy Launch Day, providing a professional platform for listed companies, unicorns, and leading innovative enterprises in niche sectors within the healthcare industry to announce major strategic updates—such as new funding rounds, product launches, partnerships, reports, or plans—and kick off the year with impact.
At this VB100 Spring Festival Strategy Launch Day, we gatheredBMJ, China Medical Imaging AI Industry-Academia-Research-Application Innovation Alliance, Yitu Healthcare, Infervision, Meet FutureIncluding five enterprises/institutions/organizations, we have joined forces with 50 leading media outlets from the healthcare, finance, and technology sectors, in addition to traditional mainstream media, to jointly witness the release of five major announcements.
>>BMJ Releases Full Suite of Multimodal Best Practice Products, Marking the Birth of the First Evidence-Based Medicine Tool for Clinical Decision-Making by Chinese Physicians
Founded in 1840 and affiliated with the British Medical Association, BMJ is a leading international publisher of medical knowledge. Its flagship journal, The BMJ (British Medical Journal), is one of the four most prestigious general medical journals worldwide. BMJ Best Practice, its clinical practice resource, is a world-class evidence-based clinical decision support system.
Following the 2018 collaboration with medical AI leader Jiahe Meikang to pioneer a new model combining an “evidence-based medicine knowledge base” with “machine learning on high-quality medical records,” BMJ is set to launch the full suite of multi-format BMJ Best Practice products. This marks BP as the first evidence-based medicine tool capable of comprehensively and instantly supporting clinical decision-making for Chinese physicians through web platforms, mobile applications, and intelligent integration with electronic medical records (EMRs), holding significant implications for improving healthcare quality and efficiency.
>> The China Medical Imaging AI Industry-Academia-Research-Application Innovation Alliance, in collaboration with ten leading enterprises, jointly released the White Paper on Medical Imaging AI in China, outlining a new blueprint for the development of medical imaging AI companies.
In recent years, the application of AI in medical imaging has flourished, yielding continuous academic and commercial achievements. However, this rapid growth has also given rise to significant hype and market irregularities. In response, the China Medical Imaging AI Industry-Academia-Research-Application Innovation Alliance convened radiology experts from top-tier (Grade 3A) hospitals across China, scientific researchers, and leading AI medical technology companies to jointly draft this professional white paper. The document analyzes the developmental value of AI in medical imaging across 15 major clinical applications, helping stakeholders gain a deep understanding of industry development models and opportunities. Furthermore, it introduces over 40 representative AI medical imaging companies, providing enterprises with a comprehensive strategic framework and direction for development.
At this press conference, the China Medical Imaging AI Industry-Academia-Research-Application Innovation Alliance, together with 10 medical artificial intelligence enterprises, jointly released the White Paper on Medical Imaging AI in China. Members of the White Paper Editorial Committee will provide an in-depth explanation of its contents to help industry stakeholders analyze development trends and identify appropriate strategic directions.
>> Yitu Healthcare Launches Intelligent Cloud Platform for Children's Health, Marking a Major Breakthrough in Achieving Child-Centric Care
Securing the top position in AI healthcare financing with $300 million, Yitu Healthcare has emerged as a dark horse over the past year, becoming China’s first unicorn in the fields of medical big data and artificial intelligence. Previously, Yitu Healthcare launched the “AI Cancer Prevention Map” initiative, covering 19 provinces, municipalities, and autonomous regions and hundreds of medical institutions. This initiative empowers early cancer screening through AI applications, extending the use cases of medical AI from healthcare institutions to the broader realm of health management, thereby ushering public health management in China into the “AI+” era.
The newly launched Intelligent Cloud Platform for Children’s Health represents a groundbreaking integration of world-class AI technologies in text, imaging, and speech. It achieves comprehensive coverage across all scenarios—from children’s health assessment to pediatric diagnosis and treatment services—spanning pre-consultation, during-consultation, and post-consultation phases. This marks a significant breakthrough in the AI healthcare industry, shifting from successful applications in single-task or single-disease-site contexts to a child-patient-centered approach.
>>Infervision Launches Advanced AI Scholar Research Platform, Enabling Medical Researchers Without Programming Skills to Conduct Deep Learning Research
As the first deep medical AI company in China to achieve clinical application, Infervision has leveraged deep learning technologies since its inception to analyze medical imaging data, including DR, CT, and MRI. It provides physicians with precise and efficient auxiliary tools, collaborates with over 250 hospitals worldwide, has assisted in the diagnosis of more than 2.5 million patients, and completed over 200,000 imaging screening cases in real-world clinical practice. Infervision’s solutions have been deployed at Shanghai Changzheng Hospital, where they have gained unanimous recognition from radiologists for significantly improving diagnostic efficiency.
Leveraging its cutting-edge technology and extensive expertise, Infervision is set to launch the InferScholar™ Center AI Scholar Research Platform. Guided by the core philosophy of empowering medical research with deep learning, this platform enables medical researchers without programming skills to conduct deep learning-based studies. It represents a truly physician-led AI solution, serving as an exclusive research assistant for doctors and providing them with a powerful tool to combat disease through AI.
>>Yu Jian Wei Lai Launches Service Platform for Patients with Cardiovascular and Cerebrovascular Diseases, Benefiting Over 24 Million Patients
With economic development and improvements in living standards, changes in dietary habits and lifestyles have led to a significant rise in the prevalence of cardiovascular and cerebrovascular diseases. In January 2019, YuJian Future, in collaboration with Huawei Health and VCBeat, and under the leadership of the National Clinical Research Center for Geriatric Diseases’ National Alliance on Cardiovascular and Cerebrovascular Diseases and the Beijing Strategic Alliance for Technological Innovation in Cerebrovascular Disease Industry, jointly released the White Paper on Cardiovascular and Cerebrovascular Health among Chinese Young and Middle-Aged Adults. This document provided strategic recommendations and insights for the management of cardiovascular and cerebrovascular health services. Guided by authoritative medical expertise, adhering to the highest industry standards in developing both professional medical content and public health education materials has become a mandatory requirement for YuJian Future’s development. Against this backdrop, YuJian Future will launch its latest cardiovascular and cerebrovascular health service platform, offering professional and authoritative prevention, diagnosis, treatment, and rehabilitation services to over 24 million patients in China, thereby enhancing attention and influence across the entire industry.
Major Announcement: Follow the Official VB100 Launch Day Website:https://vcbeat.top/vb100-voice 。
Next Stop: April 16, Shanghai, VB100 Medical Device Theme Launch Day
We will bring together the most watched listed companies, unicorns, and leading innovative enterprises in niche sectors within the medical device industry to centrally announce major developments such as new product/project launches, financing updates, partnership announcements, data reports, and strategic plans. This concentrated release of high-impact information will create a clustering effect, generating significant influence across the industry and jointly establishing the most notable launch event in the medical device sector in 2019. Meanwhile, VB100 Launch Day will invite dozens of traditional media outlets as well as media specializing in healthcare, technology, and finance to ensure in-depth coverage and precise reach to target audiences.
VB100 Official Website for Release Date:https://vcbeat.top/vb100-voice 。
We welcome collaboration with enterprises and media.